Article Details

StockNews.com Begins Coverage on BioLineRx (NASDAQ:BLRX) - The AM Reporter

Retrieved on: 2022-07-25 09:27:59

Tags for this article:

Click the tags to see associated articles and topics

StockNews.com Begins Coverage on BioLineRx (NASDAQ:BLRX) - The AM Reporter. View article details on hiswai:

Excerpt

The biotechnology company reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.05.

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up